New MS drug candidate BIIB145 begins safety testing in healthy people
NCT ID NCT07225517
First seen Nov 06, 2025 · Last updated Apr 26, 2026 · Updated 24 times
Summary
This early-stage study tests the safety of a new drug called BIIB145, which is being developed for multiple sclerosis (MS). About 104 healthy adults will receive either the drug or a placebo to see how the body handles it and if any side effects occur. The study has three parts, including single and multiple doses, and will also check how food affects the drug. Results will help decide if BIIB145 can be tested in people with MS.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
PPD Austin Clinic
RECRUITINGAustin, Texas, 78744, United States
Contact Phone: •••-•••-••••
Contact
Conditions
Explore the condition pages connected to this study.